 | • レポートコード：MRC2-11QY07313 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はフルミストワクチンのグローバル市場について調査・分析したレポートです。種類別（バクテリア、ウイルス）市場規模、用途別（病院、診療所、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別フルミストワクチンの競争状況、市場シェア ・世界のフルミストワクチン市場：種類別市場規模 2015年-2020年（バクテリア、ウイルス） ・世界のフルミストワクチン市場：種類別市場規模予測 2021年-2026年（バクテリア、ウイルス） ・世界のフルミストワクチン市場：用途別市場規模 2015年-2020年（病院、診療所、研究所、その他） ・世界のフルミストワクチン市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究所、その他） ・北米のフルミストワクチン市場分析：米国、カナダ ・ヨーロッパのフルミストワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのフルミストワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のフルミストワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのフルミストワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck、Pfizer、Astellas Pharma、Johnson & Johnson、CSL、Sanofi、Serum Institute Of India ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or “live”). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by “killing” the virus (inactivated vaccine).
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.
Market Analysis and Insights: Global Live Attenuated Vaccines Market
The global Live Attenuated Vaccines market size is projected to reach US$ 26740 million by 2026, from US$ 25090 million in 2020, at a CAGR of 6.1%% during 2021-2026.
Global Live Attenuated Vaccines Scope and Market Size
Live Attenuated Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Live Attenuated Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Live Attenuated Vaccines market is segmented into
Bacterial
Viral
Segment by Application, the Live Attenuated Vaccines market is segmented into
Hospitals
Clinics
Research Institutes
Others
Regional and Country-level Analysis
The Live Attenuated Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Live Attenuated Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Live Attenuated Vaccines Market Share Analysis
Live Attenuated Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Live Attenuated Vaccines business, the date to enter into the Live Attenuated Vaccines market, Live Attenuated Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck
Pfizer
Astellas Pharma
Johnson & Johnson
CSL
Sanofi
Serum Institute Of India
1 Study Coverage
1.1 Live Attenuated Vaccines Product Introduction
1.2 Market Segments
1.3 Key Live Attenuated Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Live Attenuated Vaccines Market Size Growth Rate by Type
1.4.2 Bacterial
1.4.3 Viral
1.5 Market by Application
1.5.1 Global Live Attenuated Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Live Attenuated Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Live Attenuated Vaccines Revenue 2015-2026
2.1.2 Global Live Attenuated Vaccines Sales 2015-2026
2.2 Global Live Attenuated Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Live Attenuated Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Live Attenuated Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Live Attenuated Vaccines Competitor Landscape by Players
3.1 Live Attenuated Vaccines Sales by Manufacturers
3.1.1 Live Attenuated Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Live Attenuated Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Live Attenuated Vaccines Revenue by Manufacturers
3.2.1 Live Attenuated Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Live Attenuated Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Live Attenuated Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Live Attenuated Vaccines Revenue in 2019
3.2.5 Global Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Live Attenuated Vaccines Price by Manufacturers
3.4 Live Attenuated Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Live Attenuated Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Live Attenuated Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Live Attenuated Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Live Attenuated Vaccines Market Size by Type (2015-2020)
4.1.1 Global Live Attenuated Vaccines Sales by Type (2015-2020)
4.1.2 Global Live Attenuated Vaccines Revenue by Type (2015-2020)
4.1.3 Live Attenuated Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Live Attenuated Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Live Attenuated Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Live Attenuated Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Live Attenuated Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Live Attenuated Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Live Attenuated Vaccines Market Size by Application (2015-2020)
5.1.1 Global Live Attenuated Vaccines Sales by Application (2015-2020)
5.1.2 Global Live Attenuated Vaccines Revenue by Application (2015-2020)
5.1.3 Live Attenuated Vaccines Price by Application (2015-2020)
5.2 Live Attenuated Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Live Attenuated Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Live Attenuated Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Live Attenuated Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Live Attenuated Vaccines by Country
6.1.1 North America Live Attenuated Vaccines Sales by Country
6.1.2 North America Live Attenuated Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Live Attenuated Vaccines Market Facts & Figures by Type
6.3 North America Live Attenuated Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Live Attenuated Vaccines by Country
7.1.1 Europe Live Attenuated Vaccines Sales by Country
7.1.2 Europe Live Attenuated Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Live Attenuated Vaccines Market Facts & Figures by Type
7.3 Europe Live Attenuated Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Live Attenuated Vaccines by Region
8.1.1 Asia Pacific Live Attenuated Vaccines Sales by Region
8.1.2 Asia Pacific Live Attenuated Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Live Attenuated Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Live Attenuated Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Live Attenuated Vaccines by Country
9.1.1 Latin America Live Attenuated Vaccines Sales by Country
9.1.2 Latin America Live Attenuated Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Live Attenuated Vaccines Market Facts & Figures by Type
9.3 Central & South America Live Attenuated Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Live Attenuated Vaccines by Country
10.1.1 Middle East and Africa Live Attenuated Vaccines Sales by Country
10.1.2 Middle East and Africa Live Attenuated Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Live Attenuated Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Live Attenuated Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Live Attenuated Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Live Attenuated Vaccines Products Offered
11.2.5 Merck Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Live Attenuated Vaccines Products Offered
11.3.5 Pfizer Related Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Corporation Information
11.4.2 Astellas Pharma Description and Business Overview
11.4.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Astellas Pharma Live Attenuated Vaccines Products Offered
11.4.5 Astellas Pharma Related Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description and Business Overview
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Live Attenuated Vaccines Products Offered
11.5.5 Johnson & Johnson Related Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Description and Business Overview
11.6.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.6.4 CSL Live Attenuated Vaccines Products Offered
11.6.5 CSL Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Live Attenuated Vaccines Products Offered
11.7.5 Sanofi Related Developments
11.8 Serum Institute Of India
11.8.1 Serum Institute Of India Corporation Information
11.8.2 Serum Institute Of India Description and Business Overview
11.8.3 Serum Institute Of India Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Serum Institute Of India Live Attenuated Vaccines Products Offered
11.8.5 Serum Institute Of India Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Live Attenuated Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Live Attenuated Vaccines Market Estimates and Projections by Region
12.1.1 Global Live Attenuated Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Live Attenuated Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Live Attenuated Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Live Attenuated Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Live Attenuated Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Live Attenuated Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Live Attenuated Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Live Attenuated Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Live Attenuated Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Live Attenuated Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Live Attenuated Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Live Attenuated Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Live Attenuated Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Live Attenuated Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Live Attenuated Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Live Attenuated Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Live Attenuated Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Live Attenuated Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Live Attenuated Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Live Attenuated Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Live Attenuated Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Live Attenuated Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Live Attenuated Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Live Attenuated Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Live Attenuated Vaccines Market Segments
Table 2. Ranking of Global Top Live Attenuated Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Live Attenuated Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Bacterial
Table 5. Major Manufacturers of Viral
Table 6. Global Live Attenuated Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Live Attenuated Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Live Attenuated Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Live Attenuated Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Live Attenuated Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Live Attenuated Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Live Attenuated Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Live Attenuated Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Live Attenuated Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Attenuated Vaccines as of 2019)
Table 15. Live Attenuated Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Live Attenuated Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Live Attenuated Vaccines Price (2015-2020) (USD/Unit)
Table 18. Live Attenuated Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Live Attenuated Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Live Attenuated Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Live Attenuated Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Live Attenuated Vaccines Sales Share by Type (2015-2020)
Table 24. Global Live Attenuated Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Live Attenuated Vaccines Revenue Share by Type (2015-2020)
Table 26. Live Attenuated Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Live Attenuated Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Live Attenuated Vaccines Sales Share by Application (2015-2020)
Table 29. North America Live Attenuated Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Live Attenuated Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Live Attenuated Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Live Attenuated Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Live Attenuated Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Live Attenuated Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Live Attenuated Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Live Attenuated Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Live Attenuated Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Live Attenuated Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Live Attenuated Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Live Attenuated Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Live Attenuated Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Live Attenuated Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Live Attenuated Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Live Attenuated Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Live Attenuated Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Live Attenuated Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Live Attenuated Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Live Attenuated Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Live Attenuated Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Live Attenuated Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Live Attenuated Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Live Attenuated Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Live Attenuated Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Live Attenuated Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Live Attenuated Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Live Attenuated Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Live Attenuated Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Live Attenuated Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Live Attenuated Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Live Attenuated Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Live Attenuated Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Live Attenuated Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Live Attenuated Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Live Attenuated Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Live Attenuated Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Live Attenuated Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Live Attenuated Vaccines Sales Market Share by Application (2015-2020)
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Major Businesses
Table 71. GlaxoSmithKline Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline Product
Table 73. GlaxoSmithKline Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Astellas Pharma Corporation Information
Table 85. Astellas Pharma Description and Major Businesses
Table 86. Astellas Pharma Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Astellas Pharma Product
Table 88. Astellas Pharma Recent Development
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Major Businesses
Table 91. Johnson & Johnson Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Recent Development
Table 94. CSL Corporation Information
Table 95. CSL Description and Major Businesses
Table 96. CSL Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. CSL Product
Table 98. CSL Recent Development
Table 99. Sanofi Corporation Information
Table 100. Sanofi Description and Major Businesses
Table 101. Sanofi Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Sanofi Product
Table 103. Sanofi Recent Development
Table 104. Serum Institute Of India Corporation Information
Table 105. Serum Institute Of India Description and Major Businesses
Table 106. Serum Institute Of India Live Attenuated Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Serum Institute Of India Product
Table 108. Serum Institute Of India Recent Development
Table 109. Global Live Attenuated Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 110. Global Live Attenuated Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Live Attenuated Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Live Attenuated Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Live Attenuated Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 114. North America: Live Attenuated Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Live Attenuated Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 116. Europe: Live Attenuated Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Live Attenuated Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 118. Asia Pacific: Live Attenuated Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Live Attenuated Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 120. Latin America: Live Attenuated Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Live Attenuated Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 122. Middle East and Africa: Live Attenuated Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Live Attenuated Vaccines Players
Table 127. Live Attenuated Vaccines Customers List
Table 128. Live Attenuated Vaccines Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Live Attenuated Vaccines Product Picture
Figure 2. Global Live Attenuated Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Bacterial Product Picture
Figure 4. Viral Product Picture
Figure 5. Global Live Attenuated Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Research Institutes
Figure 9. Others
Figure 10. Live Attenuated Vaccines Report Years Considered
Figure 11. Global Live Attenuated Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Live Attenuated Vaccines Sales 2015-2026 (K Units)
Figure 13. Global Live Attenuated Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Live Attenuated Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Live Attenuated Vaccines Sales Market Share by Region in 2019
Figure 16. Global Live Attenuated Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Live Attenuated Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Live Attenuated Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Live Attenuated Vaccines Revenue in 2019
Figure 20. Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Live Attenuated Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Live Attenuated Vaccines Sales Market Share by Type in 2019
Figure 23. Global Live Attenuated Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Live Attenuated Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Live Attenuated Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Live Attenuated Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Live Attenuated Vaccines Sales Market Share by Application in 2019
Figure 28. Global Live Attenuated Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Live Attenuated Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Live Attenuated Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Live Attenuated Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Live Attenuated Vaccines Sales Market Share by Country in 2019
Figure 33. North America Live Attenuated Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Live Attenuated Vaccines Market Share by Type in 2019
Figure 39. North America Live Attenuated Vaccines Market Share by Application in 2019
Figure 40. Europe Live Attenuated Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Live Attenuated Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Live Attenuated Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Live Attenuated Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Live Attenuated Vaccines Market Share by Type in 2019
Figure 55. Europe Live Attenuated Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Live Attenuated Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Live Attenuated Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Live Attenuated Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Live Attenuated Vaccines Revenue Market Share by Region in 2019
Figure 60. China Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Live Attenuated Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Live Attenuated Vaccines Market Share by Application in 2019
Figure 84. Latin America Live Attenuated Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Live Attenuated Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Live Attenuated Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Live Attenuated Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Live Attenuated Vaccines Market Share by Type in 2019
Figure 95. Latin America Live Attenuated Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Live Attenuated Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Live Attenuated Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Live Attenuated Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Live Attenuated Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Live Attenuated Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Live Attenuated Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Live Attenuated Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Live Attenuated Vaccines Market Share by Application in 2019
Figure 108. North America Live Attenuated Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Live Attenuated Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Live Attenuated Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Live Attenuated Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Live Attenuated Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Live Attenuated Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Live Attenuated Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Live Attenuated Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Live Attenuated Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Live Attenuated Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- ヒト用混合ワクチンの世界市場（～2026年） A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are eith…
- 獣医用ワクチンの世界市場（～2026年） Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock product…
- コンパニオンアニマル用ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Companion Animal Vaccines Market The global Companion Animal Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Companion Animal Vaccines Scope and Market Size Companion Anima…